James A. Triccas - Search Results

Year	Number of Results
2001	1
2002	3
2003	2
2004	3
2005	3
2006	3
2007	3
2008	2
2009	6
2010	6
2011	4
2012	5
2013	6
2014	4
2015	3
2016	7
2017	3
2018	6
2019	5
2020	2
2021	6

1

Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity.

Stewart E, Triccas JA, Petrovsky N. Stewart E, et al. Among authors: triccas ja. Microorganisms. 2019 Aug 12;7(8):255. doi: 10.3390/microorganisms7080255. Microorganisms. 2019. PMID: 31409028 Free PMC article. Review.

2

The generation of T-cell memory to protect against tuberculosis.

Counoupas C, Triccas JA. Counoupas C, et al. Among authors: triccas ja. Immunol Cell Biol. 2019 Aug;97(7):656-663. doi: 10.1111/imcb.12275. Epub 2019 Jun 12. Immunol Cell Biol. 2019. PMID: 31127962 Review.

3

Deciphering protective immunity against tuberculosis: implications for vaccine development.

Counoupas C, Triccas JA, Britton WJ. Counoupas C, et al. Among authors: triccas ja. Expert Rev Vaccines. 2019 Apr;18(4):353-364. doi: 10.1080/14760584.2019.1585246. Epub 2019 Mar 4. Expert Rev Vaccines. 2019. PMID: 30793629 Review.

4

New tuberculosis drug leads from naturally occurring compounds.

Quan D, Nagalingam G, Payne R, Triccas JA. Quan D, et al. Among authors: triccas ja. Int J Infect Dis. 2017 Mar;56:212-220. doi: 10.1016/j.ijid.2016.12.024. Epub 2017 Jan 3. Int J Infect Dis. 2017. PMID: 28062229 Free article. Review.

5

Recombinant BCG as a vaccine vehicle to protect against tuberculosis.

Triccas JA. Triccas JA. Bioeng Bugs. 2010 Mar-Apr;1(2):110-5. doi: 10.4161/bbug.1.2.10483. Epub 2009 Nov 2. Bioeng Bugs. 2010. PMID: 21326936 Free PMC article. Review.

6

Rapid Antibacterial Activity of Cannabichromenic Acid against Methicillin-Resistant Staphylococcus aureus.

Galletta M, Reekie TA, Nagalingam G, Bottomley AL, Harry EJ, Kassiou M, Triccas JA. Galletta M, et al. Among authors: triccas ja. Antibiotics (Basel). 2020 Aug 16;9(8):523. doi: 10.3390/antibiotics9080523. Antibiotics (Basel). 2020. PMID: 32824356 Free PMC article.

7

Novel vaccination approaches to prevent tuberculosis in children.

Triccas JA, Counoupas C. Triccas JA, et al. Pneumonia (Nathan). 2016 Nov 24;8:18. doi: 10.1186/s41479-016-0020-z. eCollection 2016. Pneumonia (Nathan). 2016. PMID: 28702297 Free PMC article. Review.

8

Mucosal delivery of a multistage subunit vaccine promotes development of lung-resident memory T cells and affords interleukin-17-dependent protection against pulmonary tuberculosis.

Counoupas C, Ferrell KC, Ashhurst A, Bhattacharyya ND, Nagalingam G, Stewart EL, Feng CG, Petrovsky N, Britton WJ, Triccas JA. Counoupas C, et al. Among authors: triccas ja. NPJ Vaccines. 2020 Nov 12;5(1):105. doi: 10.1038/s41541-020-00255-7. NPJ Vaccines. 2020. PMID: 33298977 Free PMC article.

9

Development and delivery of anti-tuberculosis drugs, vaccines and immunotherapeutics.

Triccas JA, Feng CG. Triccas JA, et al. Adv Drug Deliv Rev. 2016 Jul 1;102:1-2. doi: 10.1016/j.addr.2016.05.017. Adv Drug Deliv Rev. 2016. PMID: 27288546 No abstract available.

10

Bengamides display potent activity against drug-resistant Mycobacterium tuberculosis.

Quan DH, Nagalingam G, Luck I, Proschogo N, Pillalamarri V, Addlagatta A, Martinez E, Sintchenko V, Rutledge PJ, Triccas JA. Quan DH, et al. Among authors: triccas ja. Sci Rep. 2019 Oct 7;9(1):14396. doi: 10.1038/s41598-019-50748-2. Sci Rep. 2019. PMID: 31591407 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results